Delivery Order SPE2DB24D9113-SPE2DB25FEQDF
- Not listed
- The Defense Logistics Agency awarded a $1,113.42 firm fixed-price delivery order to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 11, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its facility in Park Ridge. This delivery order was issued without a set-aside designation, allowing the vendor to compete in the open market while leveraging its...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of YF-VAX 1 dose vials, with a completion date of September 7, 2021. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999, which runs through...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $33,402.60 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of August 28, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a single transaction under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for the supply of YF-VAX 1 dose vials, with an ultimate completion date of August 25, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order represents a continuation of DLA's pharmaceutical supply operations through its broader procurement...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price delivery order worth $2,161.50 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the YF-VAX 1 dose vaccine vials and has a completion date of November 30, 2021. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a comprehensive range of pharmaceutical...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $1,113.42 by the Defense Logistics Agency (DLA) on September 2, 2025, for YF-VAX 1 dose vials. The award is a firm fixed-price delivery order with no set-aside designation, reflecting the company's competitive standing in federal pharmaceutical procurement. Performance is scheduled for completion by September 23, 2025, at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,113.42 to DMS Pharmaceutical Group Inc. for YF-VAX 1 dose vials, with an ultimate completion date of September 3, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order utilizes firm fixed-price pricing and represents a discrete fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $1,670.13 by the Defense Logistics Agency for the supply of YF-VAX 1 Dose Vials. This firm fixed-price delivery order, issued on July 24, 2025, carries an ultimate completion date of August 14, 2025, with no set-aside designation applied to the award. The contract represents a continuation of DMS Pharmaceutical Group's substantial role...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $2,817.45, is for the delivery of YF-VAX 1 dose vials and has an ultimate completion date of August 21, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at up to $499,999,999,...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, has been awarded a delivery order valued at $27,835.50 by the Defense Logistics Agency for YF-VAX 1 dose vials. The contract is firm fixed price with no set-aside designation, reflecting the company's competitive standing in federal procurement. The delivery order is set for ultimate completion by August 15, 2025, with performance to take place at the vendor's Park Ridge, Illinois...
- SPE2DB24D9113Indefinite Delivery Contract
- SPE2DB24D9113-SPE2DB25FEQDFDelivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $2,783.55 to DMS Pharmaceutical Group Inc. for YF-VAX 1 Dose Vials, with an ultimate completion date of September 29, 2025. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected without a set-aside designation. The order will be performed at the contractor's Park Ridge facility and represents a specific product delivery under the company's larger pharmaceutical supply relationship with the federal government. This delivery order is issued under DMS Pharmaceutical Group's substantial Indefinite Delivery Contract with the Defense Logistics Agency valued at $499.999 billion through November 2026, which authorizes firm fixed-price orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. As a critical supplier in the federal pharmaceutical supply chain, DMS Pharmaceutical Group has established a robust portfolio delivering prescription medications, biologics, vaccines, and medical consumables to Department of Defense healthcare sites. The company's woman-owned small business status has enabled it to compete effectively in federal procurement markets and maintain consistent contract awards across diverse pharmaceutical product categories.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 9/8/25 |